Annovis Bio Inc. held its 2025 Annual Meeting of Stockholders virtually on June 17, 2025. Two proposals were submitted and approved. The first proposal involved the election of directors, with Maria Maccecchini, Michael Hoffman, Claudine Bruck, Reid McCarthy, and Mark White elected to the Board of Directors. The second proposal was the ratification of the appointment of Ernst & Young LLP as the company's independent auditors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.